AnalystsMaxwell SkorMaxwell Skor's Stock Forecasts
AnalystsMaxwell Skor
Sectors:
Industries:
Analyst Ranking
Top 34%
#1727 out of 5116 analysts
Average Return
+46.6%
Win Rate
67%4 out of 6
Risk vs Reward
Poor
Good
Maxwell Skor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Invivyd IncIVVD | +225.52% | $0.77 | $2.50 | 2024-11-20 - 2025-11-19 | Strong Buy |
Cidara Therapeutics IncCDTX | +115.53% | $102.02 | $219.88 | 2025-10-16 - 2025-11-28 | Strong Buy |
Sana Biotechnology IncSANA | +34.80% | $3.19 | $4.30 | 2025-07-03 - 2025-11-28 | Strong Buy |
Ascendis Pharma AASND | +21.90% | $174.18 | $212.33 | 2025-07-03 - 2025-11-28 | Strong Buy |
Maxwell Skor Analyst Color
Get additional color on Maxwell Skor's coverage of popular stocks
Maxwell Skor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $190.00 | -13.59% | Initiates Coverage On | a month ago |
Insmed IncINSM | 1 | Hold | $144.00 | -30.69% | Maintains | 3 months ago |
Ascendis Pharma AASND | 1 | Strong Buy | $250.00 | +17.74% | Assumes | 5 months ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $12.00 | +179.07% | Assumes | 5 months ago |
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $10.00 | +800.90% | Assumes | 9 months ago |
Invivyd IncIVVD | 2 | Strong Buy | $3.55 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.